Duodenal jejunal bypass liner treatment for type 2 diabetes and obesity: comparison between 9 and 12 months implantation using data from a worldwide registry

被引：0
|
作者：
Ryder, R. E. J. [1 ]
Lopez-Gonzalez, R. [2 ]
Lazzara, C. [2 ]
Gebelli, J. P. [2 ]
Munro, L. [3 ]
Frydenberg, H. [3 ]
Stein, J. [4 ]
Battelino, T. [5 ]
Fishman, S. [6 ]
Byrne, J. [7 ]
de Jonge, C. [8 ]
Greve, J. -W. [9 ]
Cohen, R. [10 ]
Yadagiri, M. [1 ]
Sen Gupta, P. [1 ,11 ]
机构：
[1] Sandwell & West Birmingham NHS Trust Hosp, Diabet, Birmingham, W Midlands, England
[2] Bellvitge Univ Hosp, Gen & Digest Surg, Barcelona, Spain
[3] Epworth Med Fdn, Richmond, Australia
[4] DGD Klin Frankfurt Sachsenhausen, Frankfurt, Germany
[5] Univ Med Ctr Ljubljana, Endocrinol Diabet & Metab, Ljubljana, Slovenia
[6] Tel Aviv Sourasky Med Ctr, Gastroenterol, Tel Aviv, Israel
[7] Univ Hosp Southampton NHS Fdn Trust, Surg, Southampton, Hants, England
[8] Maastricht Univ, Surg, Med Ctr, Maastricht, Netherlands
[9] Maastricht Univ, Med Ctr, NUTRIM, Maastricht, Netherlands
[10] Hosp Alemao Oswaldo Cruz, Sao Paulo, Brazil
[11] Guys & St Thomas NHS Fdn Trust, Diabet & Endocrinol, London, England
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
792
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [1] The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
    Selwyn van Rijn
    Bark Betzel
    Charlotte de Jonge
    David P. J. van Dijk
    Ignace M. Janssen
    Frits J. Berends
    Nicole D. Bouvy
    Jan Willem M. Greve
    Obesity Surgery, 2018, 28 : 1255 - 1262
  • [2] The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
    van Rijn, Selwyn
    Betzel, Bark
    de Jonge, Charlotte
    van Dijk, David P. J.
    Janssen, Ignace M.
    Berends, Frits J.
    Bouvy, Nicole D.
    Greve, Jan Willem M.
    OBESITY SURGERY, 2018, 28 (05) : 1255 - 1262
  • [3] Duodenal Jejunal Bypass Liner (DJBL) for treatment of type 2 diabetes and obesity: the risk benefit ratio from the worldwide EndoBarrier (EB) registry in 871 patients
    Laubner, K.
    Seufert, J.
    Aberle, J.
    Frydenberg, H.
    Munro, L.
    Fishman, S.
    Cohen, R.
    Holtmann, G.
    de Jonge, C.
    Greve, J.
    Kow, L.
    Bessell, J.
    Sourij, H.
    Benes, M.
    Ryder, R. E. J.
    DIABETOLOGIA, 2019, 62 : S390 - S390
  • [4] Duodenal jejunal bypass liner (DJBL) for treatment of type 2 diabetes and obesity: risks and benefits among 926 patients in the worldwide EndoBarrier (EB) registry
    Ryder, R. E. J.
    Sen Gupta, P.
    Stengel, R.
    Mitchell, K.
    Drummond, R.
    Frydenberg, H.
    Munro, L.
    Fishman, S.
    Cohen, R.
    de Jonge, C.
    Greve, J.
    Benes, M.
    Aberle, J.
    Laubner, K.
    Seufert, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 298 - 298
  • [5] The Duodenal–Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review
    Ingrid Zechmeister-Koss
    Mirjana Huić
    Stefan Fischer
    Obesity Surgery, 2014, 24 : 310 - 323
  • [6] Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes
    Levine, Andy
    Ramos, Almino
    Escalona, Alex
    Rodriguez, Leonardo
    Greve, Jan Willem
    Janssen, Ignace
    Rothstein, Richard
    Nepomnayshy, Dmitry
    Gersin, Keith S.
    Melanson, David
    Lamport, Ronald
    Fishman, Ezra
    Malomo, Kenneth
    Kaplan, Lee M.
    Galvao Neto, Manoel
    SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (03) : 371 - 374
  • [7] Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
    Chen, Ji-Hua
    Yu, Zi-Han
    Liu, Qin-Ling Fei
    Meng, Qing-Guo
    Chen, Xin
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3319 - 3327
  • [8] The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review
    Zechmeister-Koss, Ingrid
    Huic, Mirjana
    Fischer, Stefan
    OBESITY SURGERY, 2014, 24 (02) : 310 - 323
  • [9] Duodenal jejunal bypass liner (DJBL) treatment for type 2 diabetes and obesity: glycaemic andCVDrisk factor improvements vs risks in patients treated worldwide
    Ryder, R. E. J.
    Sen Gupta, P.
    Battelino, T.
    Kotnik, P.
    Teare, J.
    Ruban, A.
    Frydenberg, H.
    Munro, L.
    Fishman, S.
    Cohen, R.
    de Jonge, C.
    Greve, J. -W.
    Sourij, H.
    Laubner, K.
    Seufert, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S29 - S30
  • [10] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
12345